research use only
Cat.No.S4606
|
In vitro |
Water : 61 mg/mL
DMSO
: Insoluble
Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 307.32 | Formula | C10H17N3O6S |
Storage (From the date of receipt) | 3 years -20°C(in the dark) powder |
|---|---|---|---|---|---|
| CAS No. | 70-18-8 | Download SDF | Storage of Stock Solutions | Solutions are unstable. Prepare fresh or purchase small, pre-packaged sizes. Repackage upon receipt. | |
| Synonyms | Isethion, Glutathion, Tathion, L-Glutathione reduced, γ-L-Glutamyl-L-cysteinyl-glycine | SMILES | C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N | ||
Read more about storage stability CAS number SMILES
| In vitro |
Glutathione (GSH) is able to recover the meiotic failure induced by heavy metal cadmium (Cd) exposure through suppressing the excessive ROS level, DNA damage accumulation and apoptotic incidence in porcine oocytes. |
|---|---|
| In vivo |
Following GSH depletion, oral administration of this compound can increase its concentrations in several tissues. |
References |
|
(data from https://clinicaltrials.gov, updated on 2026-08-21)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07304440 | RECRUITING | Autism Spectrum Disorder; Autism; ASD; Autism Spectrum Disorder (ASD) |
Adia Med of Winter Park LLC |
2026-05-01 | PHASE1; PHASE2 |
| NCT07572890 | RECRUITING | Chronic Kidney Disease; Kidney Disease; Kidney Disease, Chronic; Chronic Kidney Disease (CKD); CKD |
Adia Med of Winter Park LLC |
2026-05-18 | PHASE1 |
| NCT02971046 | ACTIVE_NOT_RECRUITING | Healthy |
The Hospital for Sick Children |
2020-10-01 | |
| NCT05266417 | RECRUITING | Parkinson Disease |
Gateway Institute for Brain Research |
2022-02-07 | PHASE2 |
| NCT07064005 | RECRUITING | Parkinsons Disease (PD) |
Pravat Mandal |
2026-03-23 | PHASE1 |
| NCT06620523 | RECRUITING | Renal Failure; Coronary Artery Disease; Surgery; Surgery-Complications |
George Washington University |
2024-07-18 | PHASE2 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.